Cite
HARVARD Citation
Yamaguchi, A. et al. (2020). 5-year remission rate after the discontinuation of adalimumab in patients with rheumatoid arthritis: Long-term follow-up results of the HONOR study. Modern rheumatology. 30 (5), pp. 799-806. [Online].